Lynch Syndrome Pathway Navigator

Lynch Syndrome is an inherited genetic condition and represents the most common inherited cancer predisposition syndrome accounting for 5% of all colorectal (CRC) and 3% of all endometrial (EC) cancers.It affects as many as 1 in 270 people in the UK, but only 5% those affected have a diagnosis.

Cancer Alliance Planning Guidance for 2023/24 is to ensure Lynch Syndrome testing is in place for all newly diagnosed colorectal and endometrial cancers and to ensure that all patients who are identified as likely to have Lynch Syndrome are referred for specialised genetic testing in line with NICE guidelines DG27 and DG42.

This post will not lead to laboratory based experience of testing.

Secondment may be considered for internal applicants.

Cancer Alliance Planning Guidance for 2023/24 is to ensure Lynch Syndrome testing is in place for all newly diagnosed colorectal and endometrial cancers and to ensure that all patients who are identified as likely to have Lynch Syndrome are referred for specialised genetic testing in line with NICE guidelines DG27 and DG42.

The Molecular Pathology department is part of the West Kent and Medway Cellular Pathology Service and performs MMR testing on Histology specimens. The results of this inform clinical colleagues of patients who potentially have Lynch Syndrome and require further genetic referral.

The post holder will ensure that the eligible patients' samples will progress through the Pathway. It is not a technical scientific post.

Secondment may be considered for internal applicants.

Maidstone and Tunbridge Wells NHS Trust is a large acute hospital Trust in the county of Kent.

The Trust provides a full range of general hospital services and some areas of specialist complex care to around 760,000 people living in the south part of West Kent and the north part of East Sussex.

The Trust’s core catchment areas are Maidstone and Tunbridge Wells and their surrounding boroughs. We work from two main clinical sites: Maidstone Hospital and Tunbridge Wells Hospital at Pembury. Tunbridge Wells Hospital opened in 2011 and provides single rooms with en-suites for all in-patients - the first of its kind in the country.

We employ more than 7,000 full and part-time staff in a huge range of clinical and non-clinical roles across both of our hospital sites.

Once your pre-employment checks have been completed you will be contacted by Recruitment to arrange your start date which will be in line with one of our Corporate Inductions.

**Interview Date**: 22nd February 2024.

The post holder will be the point of contact for the all steps in patient pathways following a diagnosis of either colorectal or endometrial cancer and subsequent referral for MMR testing. The post holder will co-ordinate with pathology and clinical teams to arrange all necessary testing and to ensure completion of the necessary pathways in conjunction with the Lynch Syndrome Champions for both CRC and EC across sites covered.

The post holder will need to support and facilitate a co-ordinated patient experience focusing on improving the support and tracking of the patient sample through their diagnostics and investigations in a timely manner. The post holder will work within the multi-disciplinary team to support an uncomplicated rapid pathway.